Monolithic triglyceride matrices: A controlled-release system for proteins

Pharmaceutical Development and Technology

Volumn 8, Issue 1, 2003, Pages 71-79

  Vogelhuber, W ^a   Magni, E ^b   Mouro, M ^c   Spruss T ^a   Guse, C ^a   Gazzaniga, A ^b   Gopferich A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

BSA; Controlled release; Gelatin; Hyaluronidase; Implants; Triglyceride

Indexed keywords

BOVINE SERUM ALBUMIN; DYE; GELATIN; GLYCEROL DERIVATIVE; HYALURONIDASE; KETANEST; POLYMER; PROTEIN; PYRANINE; TETRAMETHYLRHODAMINE LABELED BOVINE SERUM ALBUMIN; TRIACYLGLYCEROL; TRIMYRISTIN; UNCLASSIFIED DRUG; XYLAZINE;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; DRUG MANUFACTURE; DRUG RELEASE; DRUG STABILITY; IMPLANT; IN VITRO STUDY; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TABLET COMPRESSION;

ANIMALS; BIOCOMPATIBLE MATERIALS; DELAYED-ACTION PREPARATIONS; MALE; MICE; PROTEINS; TRIGLYCERIDES;

EID: 0037233015     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-120017525     Document Type: Article

References (18)

1. Niu, C.H.; Chiu, Y.Y. FDA perspective on peptide formulation and stability issues. J. Pharm. Sci. 1998, 87 (11), 1331-1334.
2. Putney, S.D.; Burke, P.A. Improving protein therapeutics with sustained-release formulations. Nat. Biotechnol. 1998, 16 (2), 153-157.
3. Rothen-Weinhold, A.; Besseghir, K.; De Zelicourt, Y.; Gumy, R. Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analog. J. Control. Release 1998, 52 (1,2), 205-213.
4. Schwendeman, S.P.; Cardamone, M.; Klibanov, A.; Langer, R.; Brandon, M.R. Stability of proteins and their delivery from biodegradable polymer microspheres. Drugs Pharm. Sci. 1996, 1-49.
5. Shenderova, A.; Burke, T.G.; Schwendeman, S.P. Evidence for an acidic microclimate in PLGA microspheres. Proc. Int. Symp. Control. Release Bioact. Mater. 1998, 25, 265-266.
6. Brunner, A.; Mäder, K.; Göpferich, A. The chemical microenvironment inside biodegradable microspheres during erosion. Proc. Int. Symp. Control. Release Bioact. Mater. 1998, 25, 154-155.
7. Lucke, A.; Kiermaier, J.; Goepferich, A. Peptide acylation by poly(α-hydroxy esters). Pharmacol. Res. 2002, 19 (2), 175-181.
8. Reithmeier, H.; Gopferich, A.; Herrmann, J. Preparation and characterization of lipid microparticles containing thymocartin, an immunomodulating peptide. Proc. Int. Symp. Control. Release Bioact. Mater. 1999, 26, 681-682.
9. Zur, M.; Schwarz, C.; Mehnert, W. Solid lipid nanoparticles (SLN) for controlled drug delivery. Drug release and release mechanism. Eur. J. Pharm. Biopharm. 1998, 45 (2), 149-155.
10. Reithmeier, H.; Herrmann, J.; Gopferich, A. Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int. J. Pharm. 2001, 218 (1-2), 133-143.
11. Vogelhuber, W.; Magni, E.; Gazzaniga, A.; Goepferich, A.M. Monolithic glyceryl trimyristate matrices for parenteral drug release applications. Eur. J. Pharm. Biopharm. (submitted 2002).
12. Göpferich, A.; Langer, R. Modeling of polymer erosion in three dimensions: rotationally symmetric devices. AIChE J. 1995, 41 (10), 2292-2299.
13. Muckenschnabel, I.; Bernhardt, G.; Spruss, T.; Dietl, B.; Buschauer, A. Quantitation of hyaluronidases by the Morgan-Elson reaction: comparison of the enzyme activities in the plasma of tumor patients and healthy volunteers. Cancer Lett. 1998, 131 (1), 13-20.
14. Spruß, T.; Schlemmer, R.; Bernhardt, G.; Wiesenmeyer, F.; Baumann,O. Five-year breeding data, immunology and tumor take rates of an NMRI nude mouse colony. In Immunodeficient Laboratory Animals; Arnold, W., Koepf-Maier, P., Micheel, B., Eds.; Karger: Basel, 1996; 12-18.
15. Reithmeier, H. Entwicklung und charakterisierung von lipidmikropartikeln als parenterale depotarzneiform für peptide. Ph.D. Thesis; Univ. Regensburg, 1999.
16. Jiang, W.; Schwendeman, S.P. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D,L-lactide) and poly(ethylene glycol) microsphere blends. Pharmacol. Res. 2001, 18, 878-885.
17. Menzel, E.J.; Farr, C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett. 1998, 131 (1), 3-11.
18. Maschke, A.; Lucke, A; Vogelhuber, W.; Fischbach, C.; Appel, B.; Blunk, T.; Göpferich, A. Lipids: An Alternative Material for Protein and Peptide Release, ACS Symposium Series Book chapter, in preparation (2002).